BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 26025412)

  • 41. Is the flexible GnRH antagonist protocol better suited for fresh eSET cycles?
    Dahdouh EM; Gomes FL; Granger L; Carranza-Mamane B; Faruqi F; Kattygnarath TV; St-Michel P
    J Obstet Gynaecol Can; 2014 Oct; 36(10):885-891. PubMed ID: 25375301
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of different stimulation protocols efficacy in poor responders undergoing IVF: a retrospective study.
    Madani T; Ashrafi M; Yeganeh LM
    Gynecol Endocrinol; 2012 Feb; 28(2):102-5. PubMed ID: 22263965
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization.
    Morgia F; Sbracia M; Schimberni M; Giallonardo A; Piscitelli C; Giannini P; Aragona C
    Fertil Steril; 2004 Jun; 81(6):1542-7. PubMed ID: 15193474
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of triploidy incidence on clinical outcomes for IVF-ET cycles in different ovarian stimulation protocols.
    Li M; Xue X; Zhang S; Li W; Zhao X; Ren W; Shi J
    Gynecol Endocrinol; 2015 Oct; 31(10):769-73. PubMed ID: 26220642
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?
    Shavit T; Ellenbogen A; Michaeli M; Kartchovsky E; Ruzov O; Shalom-Paz E
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():46-50. PubMed ID: 24965979
    [TBL] [Abstract][Full Text] [Related]  

  • 46. GnRH-agonist ovulation trigger in patients undergoing controlled ovarian hyperstimulation for IVF with ultrashort flare GnRH-agonist combined with multidose GnRH-antagonist protocol.
    Orvieto R; Nahum R; Zohav E; Liberty G; Anteby EY; Meltcer S
    Gynecol Endocrinol; 2013 Jan; 29(1):51-3. PubMed ID: 22857268
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combined administration of gonadotropin-releasing hormone agonist with human chorionic gonadotropin for final oocyte maturation in GnRH antagonist cycles for in vitro fertilization.
    Kim CH; Ahn JW; You RM; Kim SH; Chae HD; Kang BM
    J Reprod Med; 2014; 59(1-2):63-8. PubMed ID: 24597289
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cycle scheduling with oral contraceptive pills in the GnRH antagonist protocol vs the long protocol: a randomized, controlled trial.
    Garcia-Velasco JA; Bermejo A; Ruiz F; Martinez-Salazar J; Requena A; Pellicer A
    Fertil Steril; 2011 Sep; 96(3):590-3. PubMed ID: 21718992
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Longer ovarian stimulation reduces embryo number and clinical pregnancy rate in long GnRH agonist cycles.
    Dunne C; Lawrence C; Albert A; Havelock JC
    Minerva Ginecol; 2017 Apr; 69(2):135-140. PubMed ID: 27270672
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low-dose GnRH antagonist protocol is as effective as the long GnRH agonist protocol in unselected patients undergoing in vitro fertilization and embryo transfer.
    Huang SY; Huang HY; Yu HT; Wang HS; Chen CK; Lee CL; Soong YK
    Taiwan J Obstet Gynecol; 2011 Dec; 50(4):432-5. PubMed ID: 22212313
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long gonadotropin-releasing hormone agonist versus short agonist versus antagonist regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial.
    Sunkara SK; Coomarasamy A; Faris R; Braude P; Khalaf Y
    Fertil Steril; 2014 Jan; 101(1):147-53. PubMed ID: 24188873
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predictive factors of ovarian response and clinical outcome after IVF/ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pre-treatment.
    Andersen AN; Witjes H; Gordon K; Mannaerts B;
    Hum Reprod; 2011 Dec; 26(12):3413-23. PubMed ID: 21954280
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN; Phung HT; Ho MT
    Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ANDRO-IVF: a novel protocol for poor responders to IVF controlled ovarian stimulation.
    Bercaire L; Nogueira SM; Lima PC; Alves VR; Donadio N; Dzik A; Cavagna M
    JBRA Assist Reprod; 2018 Mar; 22(1):52-55. PubMed ID: 29303236
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates.
    Acevedo B; Gomez-Palomares JL; Ricciarelli E; Hernández ER
    Fertil Steril; 2006 Dec; 86(6):1682-7. PubMed ID: 17074344
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Flexible GnRH antagonist versus flare-up GnRH agonist protocol in poor responders treated by IVF: a randomized controlled trial.
    Lainas TG; Sfontouris IA; Papanikolaou EG; Zorzovilis JZ; Petsas GK; Lainas GT; Kolibianakis EM
    Hum Reprod; 2008 Jun; 23(6):1355-8. PubMed ID: 18403419
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Short gonadotropin-releasing hormone agonist versus flexible antagonist versus clomiphene citrate regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial.
    Schimberni M; Ciardo F; Schimberni M; Giallonardo A; De Pratti V; Sbracia M
    Eur Rev Med Pharmacol Sci; 2016 Oct; 20(20):4354-4361. PubMed ID: 27831635
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Short versus Long Gonadotropin-Releasing Hormone Analogue Suppression Protocols in IVF/ICSI Cycles in Patients of Various Age Ranges.
    Ou J; Xing W; Li Y; Xu Y; Zhou C
    PLoS One; 2015; 10(7):e0133887. PubMed ID: 26208150
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Does freeze-all policy affect IVF outcome in poor ovarian responders?
    Roque M; Valle M; Sampaio M; Geber S
    Ultrasound Obstet Gynecol; 2018 Oct; 52(4):530-534. PubMed ID: 29280508
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ovarian stimulation in ART - Unwinding pressing issues.
    Zech NH; Zech M; Baldauf S; Comploj G; Murtinger M; Spitzer D; Hradecký L; Ajayi R; Schuff M; Zech H
    Minerva Ginecol; 2015 Apr; 67(2):127-47. PubMed ID: 25668422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.